Beleaguered startup Cerebral launched in 2020 with a mission to expand access to mental health services. The $4.8 billion company has served over 200,000 patients, and its ads pepper For You Pages and Instagram feeds far and wide. It’s backed by SoftBank and represented by Simone Biles.
But in 2022, the company has faced scrutiny for overprescribing controlled substances like Adderall, a Schedule II mixture of amphetamines. While most studies show that the drug is safe when taken in small doses for ADHD, it can have addictive properties when taken at large doses.
